Is CAMP4 THERAPEUTICS CORPORATION (CAMP) Stock Undervalued Ahead of Key CMP-002 Clinical Development Milestones?
TheFly reported on June 16 that JPMorgan upgraded CAMP4 to Overweight from Neutral and increased its price target to $9 from $5.
Camp4 Therapeutics Corp (CAMP)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Vivo Capital Albert Cha And Frank Kung | 4,246,568 | $18,727,365 | 1.56% | |
| 2. | Balyasny Asset Management Dmitry Balyasny | 2,632,437 | $11,609,047 | +9% | 0.02% |
| 3. | Enavate Sciences James Boylan | 2,190,920 | $9,661,957 | -28% | 2.75% |
| 4. | A16z Capital Management Marc Andreessen And Ben Horowitz | 2,125,339 | $9,372,745 | 0.73% | |
| 5. | Adage Capital Management Phill Gross And Robert Atchinson | 1,960,784 | $8,647,057 | -11% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.65 | 16,378 | $27,023.70 | 186,388 | 2026-08-03 | Filing | |
| $1.65 | 6,551 | $10,809.15 | 12,611 | 2026-08-03 | Filing | |
| $1.65 | 6,551 | $10,809.15 | 74,428 | 2026-08-03 | Filing | |
| $1.65 | 6,551 | $10,809.15 | 284,968 | 2026-08-03 | Filing | |
| $1.53 | 2,941,176 | $4,499,999.28 | 2,941,176 | 2025-09-11 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,644,134 | $7,184,865 | 0% | |
| 2. | 362,300 | $1,583,251 | 0% | |
| 3. | 83,421 | $364,550 | 0% | |
| 4. | 82,450 | $360,307 | 0% | |
| 5. | 31,589 | $138,044 | 0% |
News See All
8 Best Up and Coming Pharmaceutical Stocks to Buy Now
Investors looking for substantial potential without making a sizable initial investment continue to be drawn to inexpensive stocks.
12 Penny Stocks with Insider Buying in 2025
Insider trading can be a reliable signal for gauging the degree of confidence that management has in the future of their company.
CalAmp Corp. (NASDAQ:CAMP) Q3 2024 Earnings Call Transcript
CalAmp Corp. misses on earnings expectations. Reported EPS is $-0.12 EPS, expectations were $-0.1.
Should You Exit CalAmp Corp. (CAMP)?
Aristotle Capital Boston, LLC, an investment advisor, released its “Small Cap Equity Strategy” third quarter 2023 investor letter. A copy of the same can be downloaded here.
CalAmp Corp. (NASDAQ:CAMP) Q2 2024 Earnings Call Transcript
Operator: Welcome to CalAmp's Second Quarter 2024 Financial Results Conference Call. My name is Cole, and I'll be the moderator for today's call.
CalAmp Corp. (NASDAQ:CAMP) Q1 2024 Earnings Call Transcript
Operator: Welcome to CalAmp's First Quarter 2024 Financial Results Conference Call. My name is Bethany, and I'll be the moderator for today's call.
CalAmp Corp. (NASDAQ:CAMP) Q4 2023 Earnings Call Transcript
Operator: Welcome to CalAmp's Fourth Quarter and Fiscal Year 2023 Financial Results Conference Call. My name is Tiya and I’ll be your moderator for today’s call.
Hedge Fund and Insider Trading News: Bill Ackman, Cathie Wood, Tiger Global Management, Tenoris One, Key Square Capital Management, Crowdstrike Holdings Inc (CRWD), Box, Inc. (BOX), and More
Bill Ackman’s hedge fund, Pershing Square Capital Management, bought more shares of real estate developer Howard Hughes. Howard Hughes stock (ticker: HHC) lost a quarter of its value in 2022.
Hedge Fund and Insider Trading News: Jeff Smith, Ken Griffin, Elliott Management, Macellum Advisors, Asia Research and Capital Management, CalAmp Corp. (CAMP), Enviva Inc. (EVA), and More
The American activist hedge fund Elliott Management paid the 106 staff at its British business a combined £137 million last year after the division enjoyed a return to profit.
Hedge Fund Resource Center